Drug Discovery World

OCTOBER 16, 2023

The United Kingdom has established itself as a hub for drug discovery expertise worldwide. There is a range of reasons why this area has become focal point for drug discovery, one of which is the fact that it encompasses the University of Oxford and the University of Cambridge, two of the oldest and most prestigious universities in the world.

Drugs 190

Drugs Science Therapies Targeted Protein Degradation 190

Drug Discovery World

JULY 2, 2024

OECD data places Switzerland second in the world for biotechnology R&D intensity 1 , and in 2021, the country had the seventh largest share of the global biotech market 2. A study conducted by IQVIA and published in the 2023 Swiss Biotech Report recently showed that 20% of European biotech companies are now headquartered in Switzerland 3.

Science 148

Science Drugs Clinical Trials Licensing 148

Drug Discovery World

MAY 31, 2024

The CRO expects new markets to be a key part of its growth strategy, as biobanking and related biospecimen shipping services seek more robust solutions, particularly as a new report highlights the risk factors associated with current inventory management approaches.

Pharma Companies 130

Pharma Companies Clinical Trials Hospitals Therapies 130

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. I am a pharmacist by training and continued with a PhD in Clinical Pharmacology.

Pharma Companies 105

Pharma Companies Licensing Licensing Disease 105

Drug Discovery World

DECEMBER 6, 2023

The proposed adjustment had been criticised as unworkable and likely to result in low-margin branded medicines being withdrawn from the UK market. Criticism from the pharma industry In October, over 20 pharma companies rejected the proposed changes to the Statutory Scheme.

Government 148

Government Pharma Companies Science International 148

Drug Discovery World

FEBRUARY 5, 2024

The new data was released by pharma company Clinigen to mark the start of Rare Disease Month. Patients need to be backed by knowledge and resources, and knowing where they can get access to medicines – even before they are on the market – is vital for people with undiagnosed or rare diseases.”

Disease 130

Disease Pharma Companies Licensing Licensing 130

LifeSciVC

NOVEMBER 28, 2023

Market conditions like this are demoralizing in the worst way. We had a significantly limited set of Phase 1B data in psoriasis patients for TYK2 at the time, and we were now free to speak to pharma companies interested in our TYK2 program. By any measure, 2023 so far has seen some of the worst performance in biotech (e.g.,

Marketing 87

Marketing FDA Government Pharma Companies 87

Drug Discovery World

JANUARY 26, 2024

Dr Bentwich will present on ‘ How artificial intelligence and patient-on-a-chip are improving drug development ’ on Tuesday 6 February at 3pm. His presentation will explore the impact of Quris-AI’s Bio-AI platform in the field of drug development.

Clinical Trials 130

Clinical Trials Trials Animal Testing Pharma Companies 130

Drug Discovery World

FEBRUARY 7, 2023

The top 20 biopharmaceutical companies have recorded a growth of 5.4% in aggregate market capitalisation – from $3.43 billion over 2022, fueled by the positive performance of its top-selling immunotherapy oncology drug, Keytruda. trillion on December 31, 2021 to $3.61 trillion on December 31, 2022. billion to $281.3 for 2022.

Vaccine 130

Vaccine Pharma Companies Marketing Pharmaceuticals 130

thought leadership

MAY 29, 2023

Specialty pharma companies are focused on developing drugs for niche markets, such as rare diseases , cancer, and other complex conditions. These drugs often require significant investment in research and development, and their development requires careful project management.

Drug Development 52

Drug Development Pharma Companies Drugs Disease 52

Drug Discovery World

JULY 3, 2023

DDW’s Diana Spencer speaks to the CEOs of two drug discovery start-ups to find out how they have overcome the challenges of launching a new company in a competitive market. It’s a challenging time to launch a new company in the life sciences sector. It’s not easy being the new kid on the block.

Science 130

Science Pharma Companies Marketing Virus 130

Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. According to the Association of the British Pharmaceutical industry (ABPI), the “radical plans” are “unworkable”.

Government 130

Government Pharma Companies Science Pharmaceuticals 130

Drug Discovery World

OCTOBER 18, 2022

The group will work closely with another member, the Sustainable Health Coalition (SHC), in support of its work with the Sustainable Markets Initiative (SMI). The CoI currently has 25 members from Japan, US, and Europe, including top 10 pharma companies, CROs, and academic representatives. Growing pressure on life sciences.

Clinical Trials 130

Clinical Trials Trials Pharma Companies Science 130

Drug Discovery World

JANUARY 24, 2023

DDW Multimedia Editor Megan Thomas observes the 2023 drug discovery landscape, speaking to industry experts and looking at the foundations of 2022 on which next year will lean. The overall virtual clinical trials market is currently valued at $7.8 billion, with a projected growth of 14% per annum 1.

Clinical Trials 242

Clinical Trials Trials Drugs Treatment 242

Drug Discovery World

SEPTEMBER 28, 2022

Ben Folwell, Principal Consultant at Citeline, maps out how AI, swarm learning and open access to clinical data could revolutionise drug discovery. . Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace.

Pharma Companies 130

Pharma Companies Hospitals Clinical Trials Drugs 130

Drug Discovery World

AUGUST 22, 2023

Originator pharma companies are developing ever more complex products, which are transforming the medical landscape, but their cost places an increasing burden on healthcare budgets worldwide. This includes products with complex active ingredients or complex formulations, drug-device combination products, or complex routes of delivery.

Production 130

Production Pharma Companies Clinical Trials FDA 130

Drug Discovery World

FEBRUARY 10, 2023

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. A good part of half of those are within pharma.

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

Drug Discovery World

OCTOBER 4, 2022

DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. There’s no question that cell and gene therapies have emerged as some of the most promising and innovative medicines on the market. . Cell and gene therapies. Automation.

Drugs 130

Drugs Therapies Clinical Trials Cell Based Assays 130

Drug Discovery World

MARCH 29, 2023

Politico published a summary of the key propositions outlined in the draft 2 , and DDW’s Multimedia Editor Megan Thomas investigates their intention, and observes how the industry has responded. Key proposals Approved drugs must launch in all EU countries within two years Politico described this as a measure to ensure a level playing field.

Clinical Trials 130

Clinical Trials Biosimilars Pharma Companies Production 130

Fierce BioTech

JULY 25, 2023

How combining datasets from multiple sources can inform and improve commercial strategies Hundreds of rare disease treatments have entered the market over the past decade—thanks largely to a combination of government incentives, strong urging from patient advocacy groups and advances in cell and gene therapies.

Pharma Companies 52

Pharma Companies Government Therapies Disease 52

Drug Discovery World

JULY 3, 2024

NM: So, what we’re interested in the Milner is basically partnering between pharma and academia. We have a big consortium agreement that, at the moment, involves 14 pharma companies. MT: What are the challenges in taking this to market? ’ I think we’ve made a really good start in that area.

Research 148

Research Pharma Companies Nurses RNA 148

Drug Discovery World

APRIL 20, 2023

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. However, to invest in drug development for this condition, a number of methodological issues will need to be addressed.

Drug Development 246

Drug Development Clinical Trials Drugs Virus 246

Drug Discovery World

MAY 1, 2024

Many of the best-selling drugs in 2023 were monoclonal antibody (mAB) therapies, including Keytruda (pembrolizumab), Humira (adalimumab), and Dupixent (dupilumab) 1. Ben Holland, Co-Founder and CTO of Antiverse, notes that AI and machine learning now touch 10% of drug discovery projects.

FDA Approval 148

FDA Approval Therapies FDA Molecular Biology 148

Drug Discovery World

NOVEMBER 16, 2022

In April 2021, life sciences solutions provider Molecular Devices launched its Organoid Innovation Centre (OIC), an initiative designed to help scientists leverage the potential of 3D biology throughout the drug discovery process. . 2D vs 3D . 2D biology has been used by pharmaceutical researchers for decades. 2D vs 3D .

Pharma Companies 243

Pharma Companies Science Research Drugs 243

Drug Discovery World

APRIL 27, 2023

Megan Thomas takes a snapshot of the US biotech market and some of the ongoing research coming out of the US. In 2021, Savills put together a report on the regional hubs attracting science/pharma investment 1. It has a great overall job market, great weather, and better accessibility than other US hubs.”

Small Molecule 130

Small Molecule Science Drugs FDA Approval 130

Drug Discovery World

JULY 22, 2024

Challenges going to market The sector faces a number of challenges when it comes to bringing CGTs to market, which Loiacono reflects are indicative of broader industry issues. A few companies fully support cellular therapies, while others have consciously shied away. Previously, he served as CBO for BlueSphere.

Therapies 130

Therapies Engineering Treatment Pharma Companies 130

Drug Discovery World

AUGUST 4, 2023

Dr Christian K Schneider , Head of Biopharma Excellence at PharmaLex, presents the findings of an industry panel debate on barriers to commercialisation of novel treatments, and the most effective strategies to bring them to market. And I don’t think that’s what’s going to drive the thawing of the financial markets,” Sven noted.

Therapies 130

Therapies Pharma Companies Treatment Marketing 130

Drug Discovery World

JULY 3, 2024

NM: So, what we’re interested in the Milner is basically partnering between pharma and academia. We have a big consortium agreement that, at the moment, involves 14 pharma companies. MT: What are the challenges in taking this to market? ’ I think we’ve made a really good start in that area.

Pharma Companies 130

Pharma Companies Nurses RNA Research 130

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. African Americans).

Clinical Trials 52

Clinical Trials Drugs Trials Pharma Companies 52

H1 Blog

JULY 30, 2024

This effort seeks to provide the pharmaceutical industry with more accurate representation of patient populations, thereby enhancing the safety and efficacy for prescription drugs and medical devices. We’re curious to see what will happen over the next 12 months and how pharma companies will respond.”

FDA 59

FDA Compliance Clinical Trials Pharma Companies 59

The Pharma Data

NOVEMBER 19, 2020

In the era of “fast-moving products” and digital disruption, pharma companies are battling with customer demand to deliver products to market at increased speed and scale. In this online series, we tackle some of the key challenges affecting manufacturing, data management and R&D in the lab. . Source link.

Pharma Companies 52

Pharma Companies Production Marketing Research 52

Drug Discovery World

OCTOBER 4, 2022

Erhardt adds that despite the ever-increasing number of people with AD, there has been an erosion of market value (from $4.2 Several of the large pharma companies have recently re-entered the dementia field. The post Taking a new approach to tackle neurodegenerative diseases appeared first on Drug Discovery World (DDW).

Disease 130

Disease Small Molecule Compound Screening Clinical Development 130

Alta Sciences

APRIL 5, 2024

The mini documentary explores transformation in the slow-to-change drug development industry. Leaders from Altasciences dive into the obstacles and inefficiencies of the traditional outsourcing relationship between CROs and drug sponsors, and how Altasciences has broken from tradition to address these challenges.

Drug Development 52

Drug Development Pharma Companies Marketing International 52

The Pharma Data

AUGUST 20, 2020

Several pharma giants—including Merck, Novartis, Eli Lilly and Pfizer—have just lost procurement deals in China under the country’s new bidding system. Among the drugs to lose contracts were Eli Lilly schizophrenia medicine Zyprexa and Pfizer’s Viagra, the publication said. It’s not a completely unforeseen shift, though.

Pharma Companies 52

Pharma Companies International Marketing Research 52

Drug Discovery World

APRIL 3, 2023

I quickly recognised the commercial value of aptamers as being able to address the gap in the market where antibodies fail to perform, and together we established the business to begin aptamer development. DS: The company now has clients across big pharma. To what do you attribute your success?

Science 130

Science Molecular Biology Therapies Small Molecule 130

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. AI and big data are now commonly involved with drug discovery and development.

Clinical Trials 130

Clinical Trials Therapies Pharmaceuticals Science 130

Vial

MARCH 1, 2024

By geographical region, the global CRO services market in 2023 was dominated by North America. Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market.

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52